Seer to Report Third Quarter Financial Results on November 9, 2021
October 12 2021 - 4:05PM
Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing
a disruptive new platform for proteomics, today announced it will
report financial results for the third quarter 2021 after market
close on Tuesday, November 9, 2021. Company management will be
webcasting a conference call beginning at 1:30 p.m. Pacific Time /
4:30 p.m. Eastern Time.
Live audio of the webcast will be available on
the Investor section of Seer’s website at investor.seer.bio. An
archived replay will be available on the company’s website
following the event.
About SeerSeer is a life sciences company
developing transformative products that open up a new gateway to
the proteome. Seer is commercializing its Proteograph™
Product Suite, an integrated solution that includes proprietary
engineered nanoparticles, consumables, automation instrumentation
and software to perform deep, unbiased proteomic analysis at scale
in a matter of hours. Seer designed the Proteograph
workflow to be efficient and easy-to-use, leveraging widely adopted
laboratory instrumentation to provide a decentralized solution that
can be adopted by nearly any lab. Seer’s Proteograph Product
Suite is for research use only and is not intended for diagnostic
procedures. For more information, please
visit www.seer.bio.
Investor ContactCarrie
Mendivilinvestor@seer.bio
Media ContactKaren Possematopr@seer.bio
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jun 2024 to Jul 2024
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jul 2023 to Jul 2024